financetom
Market
financetom
/
Market
/
Data, events aplenty for Asia markets this week
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Data, events aplenty for Asia markets this week
Sep 30, 2013 12:27 AM

It`s shaping up to be a busy week for Asian markets: a possible US government shutdown looms, central banks in Japan and Australia meet, a decision on a controversial rise in Japan`s sales tax is due and a snapshot of Chinese manufacturing activity is on the agenda.

Share Market Live

NSE

Budget spending must be agreed by the US Congress before October 1 to prevent a government shutdown that could leave federal employees facing unpaid temporary leave. The prospects of the first shutdown in 17 years was looking more likely after US lawmakers failed to reach an agreement on budget funding over the weekend.

(Read more: US shutdown nears as house votes to delay health law )

"I think there is a good chance of the government shutting down, it has happened before," Paul Bloxham, HSBC`s Chief Economist for Australia and New Zealand, told CNBC Asia`s " Squawk Box ."

"But the bigger issue is the debt ceiling and that`s what markets are likely to focus on," he added. The limit for US government borrowing must be extended in October so that the US Treasury can continue to borrow money and honor its sovereign debt obligations.

(Read more: Brawl in US Congress - should the world care? )

Key week in Japan

Wrangling in US Congress aside, this week sees a number of key events in Japan that should put Tokyo in the spotlight.

Prime Minister Shinzo Abe on Tuesday is expected to unveil his decision on whether to press ahead with a controversial rise in the consumption tax next year.

The closely-watched Tankan survey of Japanese business sentiment is scheduled for release on Tuesday, while the Bank of Japan concludes a two-day policy meeting on Friday.

If Japanese media reports are anything to go by, Abe is likely to say the sales-tax increase will go ahead and unveil economic stimulus to buffer the economy from any negative impact.

"With economic data continuing to point to robust growth, there is little reason to push through legislation averting the scheduled hike," Frederic Neumann, co-head of Asian economics research at HSBC (London Stock Exchange: HSBA-GB), said in a note.

"Sticking to the plan should be a positive, demonstrating a willingness to rein in a glaring budget deficit over time. (Also) watch out for is a supplementary budget to help offset the drag from higher taxes," he added.

(Read more: Japan`s Abe to rule on sales tax rise: Will he, won`t he? )

The Bank of Japan is not expected to make any significant changes to its monetary policy when it meets.

No change from RBA?

The Reserve Bank of Australia, meanwhile, is scheduled to hold a monetary policy meeting on Tuesday and is expected to keep its key interest rates steady at a record low of 2.50 percent.

Analysts said they would watch the central bank`s statement closely amid speculation that a cycle of monetary easing is nearing an end.

The final reading of the China HSBC purchasing managers index (PMI) for September, published on Monday, came in at 50.2. That was significantly below the flash estimate of 51.2, but a touch higher than the 50.1 reading for August.

The official PMI numbers are due out on Tuesday.

"The consensus forecast, a bounce to 51.6 from 51.0, would put

Other Asian economic data due this week include the latest inflation numbers from South Korea, Indonesia, Thailand and the Philippines.

The Indian PMI data for September is also scheduled for release this week.

China starts an extended holiday period this week. National Day falls on Tuesday, October 1, which marks a week-long holiday known as Golden Week and is a key period for travel.

-By CNBC.Com`s Dhara Ranasinghe; Follow her on Twitter @DharaCNBC

Copyright 2011 cnbc.com

First Published:Sept 30, 2013 9:27 AM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Japan's Nikkei ends at record high on Wall Street gains, weaker yen
Japan's Nikkei ends at record high on Wall Street gains, weaker yen
Mar 22, 2024
(Updates to closing prices) TOKYO, March 22 (Reuters) - Japan's Nikkei share average closed at an all-time high on Friday, underpinned by record gains on Wall Street overnight and strength in automakers' stocks on a weaker yen. The Nikkei rose 0.18% to end at 40,888.43, after hitting 41,087.75 earlier in the session to break an all-time intraday high. The index,...
Sector Update: Financial
Sector Update: Financial
Mar 21, 2024
03:19 PM EDT, 03/21/2024 (MT Newswires) -- Financial stocks advanced late Thursday afternoon, with the NYSE Financial Index and the Financial Select Sector SPDR Fund (XLF) each rising 0.9%. The Philadelphia Housing Index climbed 1.8%, and the Real Estate Select Sector SPDR Fund (XLRE) was adding 0.4% Bitcoin (BTC-USD) dropped 4% to $65,176, and the yield for 10-year US Treasuries...
Japan's Nikkei hits record high on Wall Street gains, weaker yen
Japan's Nikkei hits record high on Wall Street gains, weaker yen
Mar 21, 2024
TOKYO, March 22 (Reuters) - Japan's Nikkei share average hit a record high on Friday, underpinned by the strength on Wall Street overnight and as a weaker yen prompted investors to buy automakers. The Nikkei rose to as high as 41,087.75 earlier in the session, crossing the 41,000 level for the first time. The index ended 0.07% higher at 40,844.53...
Sector Update: Health Care
Sector Update: Health Care
Mar 21, 2024
03:42 PM EDT, 03/21/2024 (MT Newswires) -- Health care stocks rose late Thursday afternoon with the NYSE Health Care Index adding 0.2% and the Health Care Select Sector SPDR Fund (XLV) rising 0.3%. The iShares Biotechnology ETF (IBB) climbed 0.9%. In corporate news, Eledon Pharmaceuticals ( ELDN ) shares surged 12% after it said its tegoprubart monoclonal antibody was used...
Copyright 2023-2026 - www.financetom.com All Rights Reserved